glp-1/glp-2 dual agonist GLP-1-based therapies for type 2 diabetes: from single, and triple agonists to endogenous GLP-1 production and L-cell differentiation | Diabetology & Metabolic Syndrome Managing symptoms with GLP-1 receptor

Tahereh Navidifar, Shoushtar Faculty of Medical Sciences, Iran

All the studies show steady, if slow, improvement in cognitive ability and physical symptoms

F.DiasL.QueirozR

The influence of l-carnitine supplementation on hematocrit and hemoglobin levels in patients with end stage renal failure on CAPD

And finally, individual susceptibility varies widelytwo people can take the same product and have entirely different experiences

Keshtmand Z, Khademian E, Poorjafari Jafroodi P, Abtahi MS, Tavakkoli Yaraki M (2023) Green synthesis of selenium nanoparticles using Artemisia chamaemelifolia : toxicity effects through regulation of gene expression for cancer cells and bacteria